Mitomycin C induced chromosomal aberrations in young cancer patients

被引:12
作者
Bakshi, SR
Patel, RK
Roy, SK
Alladi, P
Trivedi, AH
Bhatavdekar, JM
Patel, DD
Shah, PM
Rawal, UM
机构
[1] Gujarat Canc Res Inst, Dept Canc Biol, Div Cell Biol, Div Res,Gujarat Canc Soc, Ahmadabad 380016, Gujarat, India
[2] Gujarat Canc Res Inst, Dept Canc Biol, Ahmadabad 380016, Gujarat, India
[3] Gujarat Canc Res Inst, Dept Surg Oncol, Ahmadabad 380016, Gujarat, India
[4] Gujarat Canc Res Inst, Dept Med Oncol, Ahmadabad 380016, Gujarat, India
[5] Gujarat Univ, Sch Sci, Dept Zool, Ahmadabad 380009, Gujarat, India
关键词
mitomycin-C induced chromosomal aberration; pediatric cancer patient; first degree relative; mutagen sensitivity;
D O I
10.1016/S0027-5107(98)00197-3
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Mitomycin-C (MMC) induced Chromosomal aberration (CA) frequencies were studied in 48 h peripheral blood lymphocyte (PBL) cultures of untreated cancer patients of young age (maximum age 12 years, n = 77). Control population (n = 71) consisted of age-matched group (maximum age 12 years, n = 21); elder controls (minimum age 60 years, n = 19) and healthy first degree relatives, i.e., parents or siblings of the pediatric cancer patients (mean age 24.3 years, n = 31) as they share their genome and environment. Induced CA levels were found to be significantly higher among pediatric cancer patients as compared to control groups. The age-matched and elder control groups showed comparable CA levels. The first degree relatives controls showed higher induced CA levels as compared to pediatric and elder control groups. The present results indicate that there are different degrees of mutagen sensitivity prevailing in normal population. This may be responsible for differential cancer proneness. High degree of mutagen sensitivity in cancer patients may also be playing a major role in cancer onset at an early age. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:223 / 228
页数:6
相关论文
共 29 条
[1]   SCE FREQUENCIES IN LYMPHOCYTES OF TOBACCO BETEL NUT CHEWERS AND PATIENTS WITH ORAL SUBMUCOUS FIBROSIS [J].
ADHVARYU, SG ;
BHATT, RG ;
DAYAL, PK ;
TRIVEDI, AH ;
DAVE, BJ ;
VYAS, RC ;
JANI, KH .
BRITISH JOURNAL OF CANCER, 1986, 53 (01) :141-143
[2]   ARE CHROMOSOME-ABERRATIONS IN CIRCULATING LYMPHOCYTES PREDICTIVE OF FUTURE CANCER ONSET IN HUMANS - PRELIMINARY-RESULTS OF AN ITALIAN COHORT STUDY [J].
BONASSI, S ;
ABBONDANDOLO, A ;
CAMURRI, L ;
DALPRA, L ;
DEFERRARI, M ;
DEGRASSI, F ;
FORNI, A ;
LAMBERTI, L ;
LANDO, C ;
PADOVANI, P ;
SBRANA, I ;
VECCHIO, D ;
PUNTONI, R .
CANCER GENETICS AND CYTOGENETICS, 1995, 79 (02) :133-135
[3]   AN INTER-NORDIC PROSPECTIVE-STUDY ON CYTOGENETIC ENDPOINTS AND CANCER RISK [J].
BROGGER, A ;
HAGMAR, L ;
HANSTEEN, IL ;
HEIM, S ;
HOGSTEDT, B ;
KNUDSEN, L ;
LAMBERT, B ;
LINNAINMAA, K ;
MITELMAN, F ;
NORDENSON, I ;
REUTERWALL, C ;
SALOMAA, S ;
SKERFVING, S ;
SORSA, M .
CANCER GENETICS AND CYTOGENETICS, 1990, 45 (01) :85-92
[4]   CYTOGENETICS IN HEREDITARY MALIGNANT-MELANOMA AND DYSPLASTIC NEVUS SYNDROME - IS DYSPLASTIC NEVUS SYNDROME A CHROMOSOME INSTABILITY DISORDER [J].
CAPORASO, N ;
GREENE, MH ;
TSAI, S ;
PICKLE, LW ;
MULVIHILL, JJ .
CANCER GENETICS AND CYTOGENETICS, 1987, 24 (02) :299-314
[5]  
Cloos J, 1996, INT J CANCER, V68, P26, DOI 10.1002/(SICI)1097-0215(19960927)68:1<26::AID-IJC5>3.0.CO
[6]  
2-Z
[7]   CHROMOSOME FRAGILITY IN PATIENTS WITH SPORADIC UNILATERAL RETINOBLASTOMA [J].
DENUNEZ, M ;
PENCHASZADEH, VB ;
PIMENTEL, E .
CANCER GENETICS AND CYTOGENETICS, 1984, 11 (02) :139-141
[8]   MUTATION CYTOGENETICS - PAST, PRESENT AND FUTURE [J].
EVANS, HJ .
MUTATION RESEARCH, 1988, 204 (03) :355-363
[9]   ADAPTIVE RESPONSE TO 2 LOW-DOSES OF X-RAYS IN HUMAN-BLOOD LYMPHOCYTES [J].
FAN, S ;
VIJAYALAXMI ;
MINDEK, G ;
BURKART, W .
MUTATION RESEARCH, 1990, 243 (01) :53-56
[10]   GENETIC MECHANISMS IN TUMOR INITIATION AND PROGRESSION .12. CONSTITUTIONAL CHROMOSOME INSTABILITY AND CANCER RISK [J].
HEIM, S ;
JOHANSSON, B ;
MERTENS, F .
MUTATION RESEARCH, 1989, 221 (01) :39-51